• Twitter
  • Facebook
  • Linkedin
  • Mail
GVN
COVID-19 Variants and Vaccines
  • Home
  • About
    • About
    • Mission
    • Letter from the President
    • Board of Directors
    • Senior Advisors
    • Scientific Leadership Board
    • Media Inquiries
    • GVN Team
    • Partners
    • Careers at GVN
  • GVN Members
    • GVN Academic Centers of Excellence & Affiliates
    • GVN Healthcare & Pharma Centers of Excellence Coalition
    • GVN Regional Headquarters
  • Activities
    • Research
      • GVN SARS-CoV-2 Response Effort Highlights
      • SARS-CoV-2 Task Force
      • Emerging Pathogens Discovery Network Working Group
      • Zika Virus Task Force
      • HTLV-1 Task Force
      • Chikungunya Task Force
      • Translational Medicine and Clinical Research
    • Training
      • The GVN – Abbott Pandemic Defense Postdoctoral Fellowship Program
      • GVN Drs. Yang Liu & Pan Zheng Academy Program
      • 7th Annual Short Course in Basic and Translational Virology
      • Online Course on Microbiomes and their Impact on Viral Infections
      • Short Course Alumni Database
      • Hepatitis In India
    • Advocacy
      • Initiatives
      • HTLV-1 Letter
  • Publications
    • 2021 Annual Report
    • GVN COVID-19 Perspectives
    • The Other Side of Virology: Beyond the COVID-19 Pandemic
    • GVN Weekly Brief
    • GVN Webinars
    • GVN Center/Member Publications
    • GVN Center and Member Spotlights
    • GVN Previous Publications
  • Events
    • GVN-Monaco COVID-19 Diagnostic Conference
    • GVN Annual Meetings
    • Robert C. Gallo Award
    • Zika Virus Meeting
  • News
    • Press Releases
    • GVN in the News
    • Media Inquiries
    • GVN Weekly Brief
    • Join the GVN Mailing List
  • SARS-CoV-2
    • GVN Variants and Vaccine Resource Portal
    • Dr. Christian Brechot Blog
    • GVN Center & Member Spotlight
    • GVN COVID-19 Webinar Series
    • GVN SARS-CoV-2 Perspectives
    • GVN in the News
    • Saliva Testing for COVID-19
  • Members Login
  • Search
  • Menu

Unusual Surge of Respiratory Syncytial Virus in Children

September 24, 2021/in News, The Other Side of Virology: Beyond the COVID-19 Pandemic, Viral Diseases /by GVN
Read more
http://gvn.org/wp-content/uploads/2017/06/logoGVN.png 0 0 GVN http://gvn.org/wp-content/uploads/2017/06/logoGVN.png GVN2021-09-24 16:49:272021-09-24 17:07:15Unusual Surge of Respiratory Syncytial Virus in Children

Covid-19 Vaccines or Natural Immunity – Do Both Protect?

September 10, 2021/in GVN SARS-CoV-2 Perspectives, News, SARS-CoV-2 /by GVN
Read more
http://gvn.org/wp-content/uploads/2017/06/logoGVN.png 0 0 GVN http://gvn.org/wp-content/uploads/2017/06/logoGVN.png GVN2021-09-10 17:16:502021-09-10 17:16:50Covid-19 Vaccines or Natural Immunity - Do Both Protect?

News Categories

  • Awards
  • Blog
  • Board Members
  • Centers of Excellence
  • Experts
  • Flu Epidemic
  • meeting
  • News
  • Organization Structure
  • Press Release
  • Research
  • Researcher
  • SARS-CoV-2
    • GVN SARS-CoV-2 Perspectives
  • The Other Side of Virology: Beyond the COVID-19 Pandemic
  • Uncategorized
  • Vaccines
    • HIV
  • Viral Diseases
    • Camel Fever
    • Chikunguna
    • Ebola
    • Measles
  • Zika Task Force Members

Contact GVN

725 West Lombard St
Room S413
Baltimore, MD 21201
(410)-706-1966

Contact Us

Support GVN

Support

The Global Virus Network is a 501(C)3.

Join Our Mailing List

Subscribe
© Copyright - GVN - Enfold Theme by Kriesi
  • Twitter
  • Facebook
  • Linkedin
  • Mail
Scroll to top